N-acetylcysteine restores sevoflurane postconditioning cardioprotection against myocardial ischemia-reperfusion injury in diabetic rats

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Lin, Jiefu ^a   Wang, Tingting ^b,c   Li, Yalan ^a   Wang, Mengxia ^a   Li, Haobo ^b   Irwin, Michael G ^b   Xia, Zhengyuan ^b,d  

^a JINAN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADIPONECTIN; CD36 ANTIGEN; SEVOFLURANE; STAT3 PROTEIN; STREPTOZOCIN; TRANSCRIPTION FACTOR FKHR; ADIPOQ PROTEIN, RAT; ANTIOXIDANT; CREATINE KINASE MB; ETHER DERIVATIVE; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, RAT; NERVE PROTEIN; STAT3 PROTEIN, RAT; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HEART; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VIVO STUDY; INJECTION; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC POSTCONDITIONING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; SINGLE DRUG DOSE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; BLOOD; CARDIAC MUSCLE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS; PATHOLOGY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; TIME FACTOR;

ACETYLCYSTEINE; ADIPONECTIN; ANIMALS; ANTIGENS, CD36; ANTIOXIDANTS; CREATINE KINASE, MB FORM; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FORKHEAD TRANSCRIPTION FACTORS; MALE; METHYL ETHERS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NERVE TISSUE PROTEINS; OXIDATIVE STRESS; PHOSPHORYLATION; RATS, SPRAGUE-DAWLEY; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS; TROPONIN I;

EID: 84953776449     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/9213034     Document Type: Article

References (42)

1. Z. Zheng, M. Yang, F. Zhang et al., "Gender-related difference of sevoflurane postconditioning in isolated rat hearts: focus on phosphatidylinositol-3-kinase/Akt signaling," The Journal of Surgical Research, vol. 170, no. 1, pp. e3-e9, 2011.
2. T. Miki, T. Itoh, D. Sunaga, and T. Miura, "Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning," Cardiovascular Diabetology, vol. 11, article 67, 2012.
3. L. Lacerda, S. Somers, L. H. Opie, and S. Lecour, "Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway," Cardiovascular Research, vol. 84, no. 2, pp. 201-208, 2009.
4. B. Drenger, I. A. Ostrovsky, M. Barak, Y. Nechemia-Arbely, E. Ziv, and J. H. Axelrod, "Diabetes blockade of sevoflurane postconditioning is not restored by insulin in the rat heart: phosphorylated signal transducer and activator of transcription 3-and phosphatidylinositol 3-kinase-mediated inhibition," Anesthesiology, vol. 114, no. 6, pp. 1364-1372, 2011.
5. T. Wang, S. Qiao, S. Lei et al., "N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats," PLoS ONE, vol. 6, no. 8, Article ID e23967, 2011.
6. T. Wang, X. Mao, H. Li et al., "N-Acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes," Free Radical Biology and Medicine, vol. 63, pp. 291-303, 2013.
7. A. Ferdous, P. K. Battiprolu, Y. G. Ni, B. A. Rothermel, and J. A. Hill, "FoxO, autophagy, and cardiac remodeling," Journal of Cardiovascular Translational Research, vol. 3, no. 4, pp. 355-364, 2010.
8. S. M. Ronnebaumand C. Patterson, "TheFoxOfamilyincardiac function and dysfunction," Annual Review of Physiology, vol. 72, pp. 81-94, 2009.
9. Y. Zhang, F. Peng, B. Gao, A. J. Ingram, and J. C. Krepinsky, "High glucose-induced RhoA activation requires caveolae and PKCβ1-mediated ROS generation," American Journal of Physiology-Renal Physiology, vol. 302, no. 1, pp. 159-172, 2012.
10. P. K. Battiprolu, B. Hojayev, N. Jiang et al., "Metabolic stressinduced activation of FoxO1 triggers diabetic cardiomyopathy in mice,"The Journal of Clinical Investigation, vol. 122, no. 3, pp. 1109-1118, 2012.
11. P. Puthanveetil, D. Zhang, Y. Wang et al., "Diabetes triggers a PARP1 mediated death pathway in the heart through participation of FoxO1," Journal of Molecular and Cellular Cardiology, vol. 53, no. 5, pp. 677-686, 2012.
12. L. Zhan, T. Wang, W. Li, Z. C. Xu, W. Sun, and E. Xu, "Activation of Akt/FoxO signaling pathway contributes to induction of neuroprotection against transient global cerebral ischemia by hypoxic pre-conditioning in adult rats," Journal of Neurochemistry, vol. 114, no. 3, pp. 897-908, 2010.
13. S. J. Somers, M. Frias, L. Lacerda, L. H. Opie, and S. Lecour, "Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection," Cardiovascular Drugs andTherapy, vol. 26, no. 3, pp. 227-237, 2012.
14. E. E. Kershaw and J. S. Flier, "Adipose tissue as an endocrine organ," The Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2548-2556, 2004.
15. M. D. S. Afonso, G. Castilho, M. S. F. Lavrador et al., "The impact of dietary fatty acids on macrophage cholesterol homeostasis," Journal of Nutritional Biochemistry, vol. 25, no. 2, pp. 95-103, 2014.
16. Y. Bao, L. Wang, Y. Xu et al., "Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner," Atherosclerosis, vol. 223, no. 1, pp. 152-159, 2012.
17. D. Neculai, M. Schwake, M. Ravichandran et al., "Structure of LIMP-2 provides functional insights with implications for SRBI and CD36," Nature, vol. 504, no. 7478, pp. 172-176, 2013.
18. M. Y. Pepino, O. Kuda, D. Samovski, and N. A. Abumrad, "Structure-function ofCD36 and importance of fatty acid signal transduction in fat metabolism," Annual Review of Nutrition, vol. 34, pp. 281-303, 2014.
19. G. Allick, F. Sprangers, G. J. Weverling et al., "Free fatty acids increase hepatic glycogen content in obese males," Metabolism: Clinical and Experimental, vol. 53, no. 7, pp. 886-893, 2004.
20. H. Farhangkhoee, Z. A. Khan, Y. Barbin, and S. Chakrabarti, "Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction," Diabetologia, vol. 48, no. 7, pp. 1401-1410, 2005.
21. T. Hayek, K. Hussein, M. Aviram et al., "Macrophage-foam cell formation in streptozotocin-induced diabetic mice: stimulatory effect of glucose," Atherosclerosis, vol. 183, no. 1, pp. 25-33, 2005.
22. D. M. Ouwens, M. Diamant, M. Fodor et al., "Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification," Diabetologia, vol. 50, no. 9, pp. 1938-1948, 2007.
23. D. Kajimura, H. W. Lee, K. J. Riley et al., "Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1," CellMetabolism, vol. 17, no. 6, pp. 901-915, 2013.
24. A. Bonen, M. L. Parolin, G. R. Steinberg et al., "Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36," The FASEB Journal, vol. 18, no. 10, pp. 1144-1146, 2004.
25. C. C. Bastie, Z. Nahlé, T. McLoughlin et al., "FoxO1 stimulates fatty acid uptake and oxidation in muscle cells through CD36-dependent and-independent mechanisms," The Journal of Biological Chemistry, vol. 280, no. 14, pp. 14222-14229, 2005.
26. X. Jiang, E. Shi, Y. Nakajima, and S. Sato, "Inducible nitric oxide synthase mediates delayed cardioprotection induced by morphine in vivo: evidence frompharmacologic inhibition and gene-knockout mice," Anesthesiology, vol. 101, no. 1, pp. 82-88, 2004.
27. H. Li, W. Yao, M. G. Irwin et al., "Adiponectin ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction by concomitantly activatingNrf2 and Brg1," Free Radical Biology and Medicine, vol. 84, pp. 311-321, 2015.
28. Y. Liu, J. Jin, S. Qiao et al., "Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling," Clinical Science, vol. 129, no. 4, pp. 331-344, 2015.
29. J. Knapp, G. Bergmann, T. Bruckner, N. Russ, B. W. Böttiger, and E. Popp, "Pre-and postconditioning effect of Sevoflurane onmyocardial dysfunction after cardiopulmonary resuscitation in rats," Resuscitation, vol. 84, no. 10, pp. 1450-1455, 2013.
30. C. Di Filippo, S. Cuzzocrea, F. Rossi, R. Marfella, and M. DAmico, "Oxidative stress as the leading cause of acutemyocardial infarction in diabetics," Cardiovascular Drug Reviews, vol. 24, no. 2, pp. 77-87, 2006.
31. Z. Guo, Z. Xia, J. Jiang, and J. H. McNeill, "Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 292, no. 4, pp. H1728-H1736, 2007.
32. R. H. Christenson, R. T. Vollmer, E. M. Ohman et al., "Relation of temporal creatine kinase-mb release and outcome after thrombolytic therapy for acute myocardial infarction," The American Journal of Cardiology, vol. 85, no. 5, pp. 543-547, 2000.
33. A. T. Turer, K. W. Mahaffey, D. Gallup et al., "Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction," Current Controlled Trials in Cardiovascular Medicine, vol. 6, article 12, 2005.
34. Z. Xia, K.-H. Kuo, D. V. Godin, M. J. Walker, M. C. Y. Tao, and D. M. Ansley, "15-F2t-isoprostane exacerbates myocardial ischemia-reperfusion injury of isolated rat hearts," American Journal of Physiology-Heart and Circulatory Physiology, vol. 289, no. 4, pp. H1366-H1372, 2005.
35. C. R. Roe, "Validity of estimating myocardial infarct size from serial measurements of enzyme activity in the serum," Clinical Chemistry, vol. 23, no. 10, pp. 1807-1812, 1977.
36. Y. Saitoh, H. Hattori, N. Sanbe, H. Nakajima, M. Akatu, and M. Murakawa, "Delayed recovery of vecuronium neuromuscular block in diabetic patients during sevoflurane anesthesia," Canadian Journal of Anesthesia, vol. 52, no. 5, pp. 467-473, 2005.
37. Y. Kadoi, K.-I. Takahashi, S. Saito, and F. Goto, "The comparative effects of sevoflurane versus isoflurane on cerebrovascular carbon dioxide reactivity in patients with diabetes mellitus," Anesthesia and Analgesia, vol. 103, no. 1, pp. 168-172, 2006.
38. C.-P. Hsu, P. Zhai, T. Yamamoto et al., "Silent information regulator 1 protects the heart from ischemia/reperfusion," Circulation, vol. 122, no. 21, pp. 2170-2182, 2010.
39. A. Sengupta, J. D. Molkentin, J.-H. Paik, R. A. DePinho, and K. E. Yutzey, "FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress," The Journal of Biological Chemistry, vol. 286, no. 9, pp. 7468-7478, 2011.
40. H. Pei, Y. Qu, X. Lu et al., "Cardiac-derived adiponectin induced by long-terminsulin treatment amelioratesmyocardial ischemia/reperfusion injury in type 1 diabetic mice via AMPK signaling," Basic Research in Cardiology, vol. 108, no. 1, article 322, 2013.
41. R. Shibata, K. Sato, D. R. Pimentel et al., "Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK-and COX-2-dependentmechanisms," Nature Medicine, vol. 11, no. 10, pp. 1096-1103, 2005.
42. S. Baldasseroni, A. Antenore, C. Di Serio et al., "Adiponectin, diabetes and ischemic heart failure: a challenging relationship," Cardiovascular Diabetology, vol. 11, article 151, 2012.